4.8 Article

Cbx8 Acts Non-canonically with Wdr5 to Promote Mammary Tumorigenesis

Journal

CELL REPORTS
Volume 16, Issue 2, Pages 472-486

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2016.06.002

Keywords

-

Categories

Funding

  1. Office of Research Infrastructure of the NIH [S10OD018522]
  2. Department of Defense Breast Cancer Research Program [BC100975]
  3. New York Stem Cell Foundation-Druckenmiller fellowship
  4. NCI [T32 T32CA078207-11]
  5. Helmsley Trust Award
  6. NIH Pathfinder Award [DP2DK083052-01]
  7. Juvenile Diabetes Research Foundation award [JDRF-17-2010-770, R01 CA82783, R01CA184016]
  8. Samuel Waxman Cancer Research Foundation Tumor Dormancy Program award
  9. JJR Foundation
  10. Mary Kay Foundation

Ask authors/readers for more resources

Chromatin-mediated processes influence the development and progression of breast cancer. Using murine mammary carcinoma-derived tumorspheres as a functional readout for an aggressive breast cancer phenotype, we performed a loss-of-function screen targeting 60 epigenetic regulators. We identified the Polycomb protein Cbx8 as a key regulator of mammary carcinoma both in vitro and in vivo. Accordingly, Cbx8 is overexpressed in human breast cancer and correlates with poor survival. Our genomic analyses revealed that Cbx8 positively regulates Notch signaling by maintaining H3K4me3 levels on Notch-network gene promoters. Ectopic expression of Notch1 partially rescues tumorsphere formation in Cbx8-depleted cells. We find that Cbx8 associates with non-PRC1 complexes containing the H3K4 methyltransferase complex component WDR5, which together regulate Notch gene expression. Thus, our study implicates a key non-canonical role for Cbx8 in promoting breast tumorigenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available